Plasma exchange, where patient plasma is exchanged with fresh frozen plasma, is used to treat acquired TTP patients in order to remove anti-ADAMTS13 autoantibodies and to supply active ADAMTS13. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.